Christina Jewett is a Domestic Correspondent at The Times. With a strong background in investigative reporting, she focuses on health and wellness, medicine, and public policy, often asking tough questions about the effectiveness of government programs. Her impactful work has been featured in numerous outlets, including USA TODAY, CNN, and The New York Times, and has earned her prestigious awards such as the George Polk Award and the James Batten Medal.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Christina Jewett primarily covers national health-related topics, with a particular focus on government announcements, legal policy regulation, and data citations. Given this emphasis, she is likely to be most responsive to pitches that provide insider insights into FDA regulations or policies related to healthcare and pharmaceuticals in the United States.
She often cites data in her articles which suggests she highly values evidence-based reporting. Pitches offering access to exclusive data or unique research findings related to healthcare trends or pharmaceutical industry developments may resonate well with her.
Given her coverage of drug shortages and cancer treatment issues, sources who can offer firsthand accounts of these challenges or new strategies for addressing them may capture Christina's interest.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Karoun Demirjian, Dana G. Smith, David E. Sanger, Brad Plumer, David M. Halbfinger, Christina Jewett, David Halbfinger, Vivian Nereim, Leo Sands
Trump Live Updates: President Says U.S.-Saudi Nuclear Deal ‘Subject to’ Normalizing Relations With Israel
By: Edison Wu, Lazaro Gamio, Michael M. Grynbaum, Christina Jewett, Dana G. Smith, Ana Swanson, Jonah E. Bromwich, Sheryl Gay Stolberg, Tony Romm
Trump Live Updates: Latest News on Tariffs, Peptides and More
By: Christina Jewett, Kenneth P. Vogel, Olivia Diaz
At the White House’s request, senators tucked a change sought by the hemp industry into a crucial spending bill. It would benefit the son-in-law of Susie Wiles, the president’s chief of staff.
By: Kenneth P. Vogel, Olivia Diaz, Christina Jewett
WASHINGTON — The White House is lobbying Congress for a reprieve from a ban it approved last year on potent intoxicating hemp products, seeking a
The agency had initially refused to even review the application but reversed course after a public outcry.
By The Food and Drug Administration on Wednesday approved the first mRNA flu vaccine, enabling use of a technology that will make it easier
By: Paige Cowett, Eric Krupke, Diane Wong, Olivia Natt, Alyssa Moxley, Diana Nguyen, Caroline Hopkins Legaspi, Michael Barbaro, Marion Lozano, Alex Stern, Liz O. Baylen, Dan Powell, Christina Jewett
The parasite cyclospora, which spreads through food or water contaminated by human feces, has been traced to a Taylor Farms processing facility in Mexico.
By: Kenneth P. Vogel, Christina Jewett, Olivia Diaz
The White House is lobbying Congress for a reprieve from a ban it approved last year on potent intoxicating hemp products, seeking a delay whose beneficiaries would include the son-in-law of Susie Wiles, President Trump’s chief of staff. Under pressure from the administration, senators tucked the delay into a stopgap spending measure they are working to pass this week in an effort to head off a government shutdown at the end of September.
By: Christina Jewett, Julie Creswell
WASHINGTON -- Cases of cyclosporiasis were mounting rapidly in Michigan, and state health officials were homing in on a common thread: Many of those who had fallen ill had eaten at Taco Bell.
By: Christina Jewett
Dr. Overton is a fierce opponent of abortion rights and a supporter of Health Secretary Robert F. Kennedy Jr.’s Make America Healthy Again agenda.
